Citron Research Takes it to Intuitive Surgical (ISRG) Again

Go back to Citron Research Takes it to Intuitive Surgical (ISRG) Again

Intuitive Surgical (ISRG) Q3 Procedure Growth Rate 16% - Wedbush

October 8, 2013 2:09 PM EDT

Wedbush today maintained an Outperform rating on Intuitive Surgical (NASDAQ: ISRG) with a price target of $495.00. Analyst Tao Levy sees approximately 16% procedure growth rate for 3Q13.

"Based on our breakdown of Intuitive Surgical's MAUDE Database Analysis the company posted on its website Thursday evening and updated over the weekend, we estimate that the yet-to-be-reported 3Q13... More

Intuitive (ISRG), Mazor (MZOR) on Watch Following Negative Article

October 8, 2013 8:36 AM EDT

Intuitive Surgical (Nasdaq: ISRG), Mazor Robotics Ltd. (Nasdaq: MZOR), and Accuray Inc. (Nasdaq: ARAY) shares are on watch following a negative outlook on the near-term future of robotic surgery.
... More

Intuitive Surgical (ISRG) Falls on New Citron Report

October 3, 2013 10:47 AM EDT

Intuitive Surgical, Inc. (NASDAQ: ISRG) is seeing midday weakness following a updated report from Citron Research, placing a $200 price target on the stock. Shares are down 2.2% mid-day.

Link... More